Article metrics

Download PDFPDF

S4 Implications of guidance in scotland on eligibility for treatment with mepolizumab and omalizumab – an ideal study analysis
Free

 

Online download statistics by month:

Online download statistics by month: November 2016 to July 2022

AbstractFullPdf
Nov 20169209
Dec 20162003
Jan 20175507
Feb 20172602
Mar 20171402
Apr 201733011
May 20172000
Jun 20172302
Jul 20174201
Aug 20173600
Sep 20173803
Oct 20172802
Nov 20172202
Dec 20172600
Jan 20184203
Feb 20183801
Mar 20182200
Apr 20183200
May 20185201
Jun 20183400
Jul 20182000
Aug 20182600
Sep 20181000
Oct 20181200
Nov 2018400
Dec 20181200
Jan 2019900
Feb 2019701
Mar 20192000
Apr 20191300
May 2019602
Jun 2019600
Jul 20191200
Aug 20192700
Sep 2019900
Oct 20191400
Nov 20191804
Dec 2019502
Jan 20201502
Feb 20201002
Mar 2020402
Apr 20201904
May 2020403
Jun 2020807
Jul 20201603
Aug 2020101
Sep 20201804
Oct 2020601
Nov 2020804
Dec 2020601
Jan 20211401
Feb 2021102
Mar 2021602
Apr 2021202
May 2021402
Jun 2021002
Jul 2021007
Aug 2021002
Sep 2021006
Oct 202110018
Nov 20216014
Dec 20211803
Jan 2022802
Feb 2022701
Mar 2022202
Apr 20221201
May 20221408
Jun 2022503
Jul 2022802
Total11570172